Synovis Life Technologies, Inc. (NASDAQ:SYNO) has announced that it will be speaking at the 22nd Annual Roth Capital Partners Growth Stock Conference on March 15. The conference will be held at The Ritz-Carlton in Dana Point, California march 15-17. Speaking on behalf of the company will be its chief financial officer Brett Reynolds, and president and chief executive officer Richard Kramp. Kramp and Reynolds will begin their presentation at 8:00 am PT Monday morning to discuss Synovis’ recent performance and market opportunities. For more information about the event, visit http://www.synovislife.com/.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Synovis Life Technologies, Inc. (Synovis) is a diversified medical device company engaged in developing, manufacturing and marketing mechanical and biological products used by surgical specialties for the repair of soft tissue damaged or destroyed by disease or injury. Synovis’s products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools. On July 17, 2009, the Company, through its wholly owned subsidiary Synovis Orthopedic and Woundcare, Inc. (Ortho & Wound), acquired Pegasus Biologics, Inc.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
